Table 2.
Quality Indicator | Cancer Study Population | Qualified Study Sample (No. of patients) | Yes Results (%) |
---|---|---|---|
Preoperative CT scan of abdomen and pelvis prior to definitive surgical resection | Stages II and III colorectal cancer | 1,729 | 72.1 |
Preoperative CEA determination prior to definitive surgical resection | Stages II and III colorectal cancer | 1,729 | 82.8 |
Documented radial margins were free of tumor at the time definitive surgical resection | Stages II and III colorectal cancer | 1,725* | 81.2† |
Referral to a medical oncologist | Stages II and III colorectal cancer | 1,729 | 77.5 |
Adjuvant FU or capecitabine administered after definitive surgical resection | Stage III colorectal cancer | 808 | 73.5 |
Surveillance colonoscopy within 7 to 18 months after definitive surgical resection for patients with documentation of no preoperative obstructing lesion | Stages I, II, and III colorectal cancer with no preoperative obstructing lesion documented | 1,259 | 43.5 |
Abbreviations: CT, computed tomography; CEA, carcinoembryonic antigen; FU, fluorouracil.
Margins question was missing with four patients.
Of the 1.725 patients for whom the abstraction question pertaining to clear margins was answered, 1400 (81.2%) had documentation of clear margins, 207 (12.0%) had medical record indication that margins were not clear, and for 118 (6.8%) abstractors could not ascertain the margin status from the medical record.